HOUSTON (AP) _ Salarius Pharmaceuticals, Inc. (SLRX) on Thursday reported a loss of $3.1 million in its second quarter.

On a per-share basis, the Houston-based company said it had a loss of 7 cents.

The biotech drug developer posted revenue of $571,400 in the period. Its adjusted revenue was $571,000.

The company's shares closed at 80 cents. A year ago, they were trading at $1.19.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SLRX at https://www.zacks.com/ap/SLRX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News